JOURNÉES DE L'INNOVATION EN BIOLOGIE 2019

Everything is based on an observation: if there is a sector of health that is revolutionary, it is medical biology. Everything evolves, everything accelerates; the JIB had to modify its axis to anticipate and accompany these changes.

The consolidation of private laboratories, followed by the restructuring of public laboratories within the regional hospital groups (GHT), the communication of new techniques and therapies (molecular biology, etc.), the arrival of artificial intelligence after the advent of automation.

Medical biologists, industry and suppliers are challenged to reinvent medical biology to benefit everyone, and over and above all, to benefit the patient. The Innovation in Biology Conference (JIB) will provide a place for discovery, for sharing, for debate and for training.

The JIB reflects the eagerness of biologists to make innovation in medical biology accessible to all patients to improve care, from screening to monitoring treatments. It also intends to provide a platform for all biology stakeholders to seize opportunities for innovation, thus contributing to the evolution of medical practices.

The Innovation in Biology Conference (JIB) goes beyond the annual meeting that consists of scientific sessions and exhibitions; it lives throughout the year by positioning itself as an incubator where innovations and transformations are revealed, practised and challenged.

The structure of the French and International Scientific committees proves that this approach is in favour of success for all.

Over 2 days the JIB will host a succession of scientific sessions and workshops. Bringing innovation to life, the scientific and organising committees will be shaking up the usual format of medical and scientific meetings with sessions and round tables that will highlight the characteristics of medical biology for today and for tomorrow; diverse, tranverse:

What are the scientific and technical innovations being prepared in France and abroad ?

• Where is research in medical biology ?
• What are the IVD stakeholders preparing for tomorrow’s medical biology ?
• What role will medical biologists play in the development of TRODs and self-tests and offshore biology ?
• What are the organizational models of the relevant laboratories of tomorrow ?

How medical biology laboratories help improve patient care:

• What is the role of medical biology in personalized medicine ?
• What is the relationship between medical biologists and their patients ?
• How can biologists optimize screening procedures ?

Likewise, the exhibition will be transformed to its core with a space of exchanges and discoveries, the Agora Tech, which will be host throughout the two days presentations putting technological innovation at the heart of the debate.